Position in VRTX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$457,985
+$126,126 QoQ
Shares Held
922
+26.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#190
of 365 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GK Wealth Management LLC holds $1,849,302 across 6 Biotechnology names. VRTX ranks #2 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
6,188 | $701,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
922 | $457,985 | |
| 3 | ANRO |
Alto Neuroscience, Inc.
|
8,565 | $226,030 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
337 | $210,132 | |
| 5 | ARDX |
Ardelyx, Inc.
|
40,868 | $208,426 | |
| 6 | ELDN |
Eledon Pharmaceuticals, Inc.
|
11,487 | $45,258 |
All Filings in VRTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,985 | 922 | Shares | Defined | 2026-07-07 | |
| 2025-12-31 | $331,859 | 732 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $300,387 | 767 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $306,742 | 689 | Shares | Defined | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||